ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

MDC Mediclinic International Plc

501.00
0.00 (0.00%)
20 Dec 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mediclinic International Plc LSE:MDC London Ordinary Share GB00B8HX8Z88 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 501.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Magnetar Capital Partners LP Form 8.3 - Mediclinic International Plc

24/05/2023 1:44pm

UK Regulatory


 
TIDMMDC 
 
FORM 8.3 
 
           PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY 
 
    A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 
 
                  Rule 8.3 of the Takeover Code (the "Code") 
 
1.         KEY INFORMATION 
 
(a) Full name of discloser:                       Magnetar Capital Partners LP 
 
(b) Owner or controller of interests and short 
positions disclosed, if different from 1(a): 
     The naming of nominee or vehicle companies 
is insufficient.  For a trust, the trustee(s), 
settlor and beneficiaries must be named. 
 
(c) Name of offeror/offeree in relation to whose  Mediclinic International plc 
relevant securities this form relates: 
     Use a separate form for each offeror/offeree 
 
(d) If an exempt fund manager connected with an 
offeror/offeree, state this and specify identity 
of offeror/offeree: 
 
(e) Date position held/dealing undertaken:        23/05/2023 
     For an opening position disclosure, state 
the latest practicable date prior to the 
disclosure 
 
(f)  In addition to the company in 1(c) above, is NO 
the discloser making disclosures in respect of 
any other party to the offer? 
     If it is a cash offer or possible cash 
offer, state "N/A" 
 
2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE 
 
If there are positions or rights to subscribe to disclose in more than one 
class of relevant securities of the offeror or offeree named in 1(c), copy 
table 2(a) or (b) (as appropriate) for each additional class of relevant 
security. 
 
(a)        Interests and short positions in the relevant securities of the 
offeror or offeree to which the disclosure relates following the dealing (if 
any) 
 
Class of relevant security:                        10p ordinary 
 
                                         Interests           Short positions 
 
                                       Number        %         Number        % 
 
(1) Relevant securities owned and 
/or controlled: 
 
(2) Cash-settled derivatives:        15,233,047     2.06 
 
(3) Stock-settled derivatives 
(including options) and 
agreements to purchase/sell: 
 
                                     15,233,047     2.06 
     TOTAL: 
 
All interests and all short positions should be disclosed. 
 
Details of any open stock-settled derivative positions (including traded 
options), or agreements to purchase or sell relevant securities, should be 
given on a Supplemental Form 8 (Open Positions). 
 
(b)        Rights to subscribe for new securities (including directors' and 
other employee options) 
 
Class of relevant security in relation 
to which subscription right exists: 
 
Details, including nature of the rights 
concerned and relevant percentages: 
 
3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE 
 
Where there have been dealings in more than one class of relevant securities of 
the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as 
appropriate) for each additional class of relevant security dealt in. 
 
The currency of all prices and other monetary amounts should be stated. 
 
(a)        Purchases and sales 
 
   Class of relevant       Purchase/sale    Number of   Price per unit 
        security                            securities 
 
(b)        Cash-settled derivative transactions 
 
  Class of     Product       Nature of       Number of     Price per 
  relevant   description      dealing        reference        unit 
  security     e.g. CFD    e.g. opening/    securities 
                          closing a long/ 
                          short position, 
                            increasing/ 
                          reducing a long 
                          /short position 
 
   Common        Swap      Increasing a        7,710      GBP5.005000 
                           long position 
 
   Common        Swap      Increasing a         401       GBP5.000012 
                           long position 
 
   Common        Swap      Increasing a         437       GBP5.000023 
                           long position 
 
(c)        Stock-settled derivative transactions (including options) 
 
(i)         Writing, selling, purchasing or varying 
 
Class of   Product    Writing,   Number of  Exercise    Type    Expiry   Option 
relevant description purchasing, securities price per   e.g.     date    money 
security  e.g. call   selling,    to which    unit    American,          paid/ 
           option      varying     option             European          received 
                        etc.      relates               etc.            per unit 
 
(ii)        Exercise 
 
   Class of         Product      Exercising/      Number of     Exercise price per 
   relevant       description     exercised      securities            unit 
   security     e.g. call option   against 
 
(d)        Other dealings (including subscribing for new securities) 
 
Class of relevant     Nature of dealing           Details      Price per unit (if 
    security          e.g. subscription,                           applicable) 
                          conversion 
 
4.         OTHER INFORMATION 
 
(a)        Indemnity and other dealing arrangements 
 
Details of any indemnity or option arrangement, or any agreement or 
understanding, formal or informal, relating to relevant securities which may be 
an inducement to deal or refrain from dealing entered into by the person making 
the disclosure and any party to the offer or any person acting in concert with 
a party to the offer: 
Irrevocable commitments and letters of intent should not be included.  If there 
are no such agreements, arrangements or understandings, state "none" 
 
 
None 
 
(b)        Agreements, arrangements or understandings relating to options or 
derivatives 
 
Details of any agreement, arrangement or understanding, formal or informal, 
between the person making the disclosure and any other person relating to: 
(i)  the voting rights of any relevant securities under any option; or 
(ii) the voting rights or future acquisition or disposal of any relevant 
securities to which any derivative is referenced: 
If there are no such agreements, arrangements or understandings, state "none" 
 
 
None 
 
(c)        Attachments 
 
Is a Supplemental Form 8 (Open Positions) attached?                      NO 
 
 
 
Date of disclosure:                      24/05/2023 
 
Contact name:                            Julianna Ethell 
 
Telephone number:                        847-905-4688 
 
Public disclosures under Rule 8 of the Code must be made to a Regulatory 
Information Service. 
 
The Panel's Market Surveillance Unit is available for consultation in relation 
to the Code's disclosure requirements on +44 (0)20 7638 0129. 
 
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk. 
 
 
 
END 
 
 

(END) Dow Jones Newswires

May 24, 2023 08:44 ET (12:44 GMT)

1 Year Mediclinic Chart

1 Year Mediclinic Chart

1 Month Mediclinic Chart

1 Month Mediclinic Chart

Your Recent History

Delayed Upgrade Clock